Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs LH✓SelectedUSD · LHGSK vs LH performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs LH

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+41.1%
LH return
+59.7%
Excess return
-18.6%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioLHExcessAlpha
1D-0.1%-0.5%+0.3%0.0%
7D-5.3%-0.9%-4.4%-5.1%
30D-3.7%+13.4%-17.1%-6.9%
3M-7.3%+10.5%-17.8%-9.8%
6M-4.2%+43.3%-47.6%-13.0%
YTD+0.9%+47.4%-46.6%-9.2%
1Y+7.3%+41.8%-34.6%-2.5%
3Y+52.7%+79.5%-26.7%+30.5%
All+41.1%+59.7%-18.6%+20.6%

Cumulative growth

Daily Returns

Daily percentage return beside LH.

Daily Out/Under-Performance

Portfolio return minus LH return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × LH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded LH wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling